Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study. Sorensen PS, Lisby S, Grove R, Derosier F, Shackelford S, Havrdova E, Drulovic J, Filippi M Neurology. 2014 Feb 18; 82(7):573-81. PMID: 24453078. Abstract CommentRecommendBookmarkWatch